{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:04:53Z","timestamp":1791493493670,"version":"4.3.4"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,6,10]],"date-time":"2015-06-10T00:00:00Z","timestamp":1433894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00262-015-1720-6","type":"journal-article","created":{"date-parts":[[2015,6,10]],"date-time":"2015-06-10T19:16:46Z","timestamp":1433963806000},"page":"453-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?"],"prefix":"10.1007","volume":"65","author":[{"given":"Beatriz","family":"Sanchez-Correa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Pera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Bergua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Arcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Ba\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier G.","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Solana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Tarazona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,10]]},"reference":[{"key":"1720_CR1","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s00262-004-0517-9","volume":"53","author":"I Algarra","year":"2004","unstructured":"Algarra I, Garcia-Lora A, Cabrera T, Ruiz-Cabello F, Garrido F (2004) The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. Cancer Immunol Immunother 53:904\u2013910","journal-title":"Cancer Immunol Immunother"},{"key":"1720_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.humimm.2011.01.009","volume":"72","author":"A Almeida-Oliveira","year":"2011","unstructured":"Almeida-Oliveira A, Smith-Carvalho M, Porto LC, Cardoso-Oliveira J, Ribeiro AS, Falcao RR, Abdelhay E, Bouzas LF, Thuler LC, Ornellas MH, Diamond HR (2011) Age-related changes in natural killer cell receptors from childhood through old age. Hum Immunol 72:319\u2013329","journal-title":"Hum Immunol"},{"key":"1720_CR3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature14189","volume":"517","author":"D Artis","year":"2015","unstructured":"Artis D, Spits H (2015) The biology of innate lymphoid cells. Nature 517:293\u2013301","journal-title":"Nature"},{"key":"1720_CR4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1615\/CritRevOncog.2014011091","volume":"19","author":"V Bachanova","year":"2014","unstructured":"Bachanova V, Miller JS (2014) NK cells in therapy of cancer. Crit Rev Oncog 19:133\u2013141","journal-title":"Crit Rev Oncog"},{"key":"1720_CR5","first-page":"221","volume":"14","author":"L Balducci","year":"2000","unstructured":"Balducci L, Yates J (2000) General guidelines for the management of older patients with cancer. Oncology (Williston Park) 14:221\u2013227","journal-title":"Oncology (Williston Park)"},{"key":"1720_CR6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0531-5565(98)00076-X","volume":"34","author":"F Borrego","year":"1999","unstructured":"Borrego F, Alonso MC, Galiani MD, Carracedo J, Ramirez R, Ostos B, Pena J, Solana R (1999) NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol 34:253\u2013265","journal-title":"Exp Gerontol"},{"key":"1720_CR7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.20030788","volume":"198","author":"C Bottino","year":"2003","unstructured":"Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, Reymond N, Vitale M, Moretta L, Lopez M, Moretta A (2003) Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198:557\u2013567","journal-title":"J Exp Med"},{"key":"1720_CR8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1479-5876-11-289","volume":"11","author":"TA Braciak","year":"2013","unstructured":"Braciak TA, Wildenhain S, Roskopf CC, Schubert IA, Fey GH, Jacob U, Hopfner KP, Oduncu FS (2013) NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2. J Transl Med 11:289","journal-title":"J Transl Med"},{"key":"1720_CR9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","volume":"112","author":"MA Caligiuri","year":"2008","unstructured":"Caligiuri MA (2008) Human natural killer cells. Blood 112:461\u2013469","journal-title":"Blood"},{"key":"1720_CR10","doi-asserted-by":"crossref","first-page":"195956","DOI":"10.1155\/2012\/195956","volume":"2012","author":"X Camous","year":"2012","unstructured":"Camous X, Pera A, Solana R, Larbi A (2012) NK cells in healthy aging and age-associated diseases. J Biomed Biotechnol 2012:195956","journal-title":"J Biomed Biotechnol"},{"key":"1720_CR11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.imlet.2014.06.015","volume":"162","author":"C Campos","year":"2014","unstructured":"Campos C, Pera A, Lopez-Fernandez I, Alonso C, Tarazona R, Solana R (2014) Proinflammatory status influences NK cells subsets in the elderly. Immunol Lett 162:298\u2013302","journal-title":"Immunol Lett"},{"key":"1720_CR12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.exger.2014.01.008","volume":"54","author":"C Campos","year":"2014","unstructured":"Campos C, Pera A, Sanchez-Correa B, Alonso C, Lopez-Fernandez I, Morgado S, Tarazona R, Solana R (2014) Effect of age and CMV on NK cell subpopulations. Exp Gerontol 54:130\u2013137","journal-title":"Exp Gerontol"},{"key":"1720_CR13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-4933-3-10","volume":"3","author":"SM Chidrawar","year":"2006","unstructured":"Chidrawar SM, Khan N, Chan YL, Nayak L, Moss PA (2006) Ageing is associated with a decline in peripheral blood CD56bright NK cells. Immun Ageing 3:10","journal-title":"Immun Ageing"},{"key":"1720_CR14","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood.V99.10.3661","volume":"99","author":"RT Costello","year":"2002","unstructured":"Costello RT, Sivori S, Marcenaro E, Lafage-Pochitaloff M, Mozziconacci MJ, Reviron D, Gastaut JA, Pende D, Olive D, Moretta A (2002) Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99:3661\u20133667","journal-title":"Blood"},{"key":"1720_CR15","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood-2011-01-329508","volume":"118","author":"A Curti","year":"2011","unstructured":"Curti A, Ruggeri L, D\u2019Addio A, Bontadini A, Dan E, Motta MR, Trabanelli S, Giudice V, Urbani E, Martinelli G, Paolini S, Fruet F, Isidori A, Parisi S, Bandini G, Baccarani M, Velardi A, Lemoli RM (2011) Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. Blood 118:3273\u20133279","journal-title":"Blood"},{"key":"1720_CR16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/icb.2013.95","volume":"92","author":"LF Andrade de","year":"2014","unstructured":"de Andrade LF, Smyth MJ, Martinet L (2014) DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins. Immunol Cell Biol 92:237\u2013244","journal-title":"Immunol Cell Biol"},{"key":"1720_CR17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-4933-5-11","volume":"5","author":"E Derhovanessian","year":"2008","unstructured":"Derhovanessian E, Solana R, Larbi A, Pawelec G (2008) Immunity, ageing and cancer. Immun Ageing 5:11","journal-title":"Immun Ageing"},{"key":"1720_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0047-6374(98)00156-0","volume":"108","author":"G Lorenzo Di","year":"1999","unstructured":"Di Lorenzo G, Balistreri CR, Candore G, Cigna D, Colombo A, Romano GC, Colucci AT, Gervasi F, Listi F, Potestio M, Caruso C (1999) Granulocyte and natural killer activity in the elderly. Mech Ageing Dev 108:25\u201338","journal-title":"Mech Ageing Dev"},{"key":"1720_CR19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.leukres.2014.11.027","volume":"39","author":"HP Erba","year":"2015","unstructured":"Erba HP (2015) Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy. Leuk Res 39:183\u2013191","journal-title":"Leuk Res"},{"key":"1720_CR20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF02983234","volume":"78","author":"SS Farag","year":"2003","unstructured":"Farag SS, VanDeusen JB, Fehniger TA, Caligiuri MA (2003) Biology and clinical impact of human natural killer cells. Int J Hematol 78:7\u201317","journal-title":"Int J Hematol"},{"key":"1720_CR21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2005-08-027979","volume":"109","author":"C Fauriat","year":"2007","unstructured":"Fauriat C, Just-Landi S, Mallet F, Arnoulet C, Sainty D, Olive D, Costello RT (2007) Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction. Blood 109:323\u2013330","journal-title":"Blood"},{"key":"1720_CR22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000328005","volume":"3","author":"I Gayoso","year":"2011","unstructured":"Gayoso I, Sanchez-Correa B, Campos C, Alonso C, Pera A, Casado JG, Morgado S, Tarazona R, Solana R (2011) Immunosenescence of human natural killer cells. J Innate Immun 3:337\u2013343","journal-title":"J Innate Immun"},{"key":"1720_CR23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fphar.2015.00021","volume":"6","author":"W Glienke","year":"2015","unstructured":"Glienke W, Esser R, Priesner C, Suerth JD, Schambach A, Wels WS, Grez M, Kloess S, Arseniev L, Koehl U (2015) Advantages and applications of CAR-expressing natural killer cells. Front Pharmacol 6:21","journal-title":"Front Pharmacol"},{"key":"1720_CR24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.humimm.2010.03.014","volume":"71","author":"RP Hayhoe","year":"2010","unstructured":"Hayhoe RP, Henson SM, Akbar AN, Palmer DB (2010) Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset. Hum Immunol 71:676\u2013681","journal-title":"Hum Immunol"},{"key":"1720_CR25","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.arr.2013.04.003","volume":"12","author":"J Hazeldine","year":"2013","unstructured":"Hazeldine J, Lord JM (2013) The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev 12:1069\u20131078","journal-title":"Ageing Res Rev"},{"key":"1720_CR26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ijc.2910160205","volume":"16","author":"RB Herberman","year":"1975","unstructured":"Herberman RB, Nunn ME, Holden HT, Lavrin DH (1975) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 16:230\u2013239","journal-title":"Int J Cancer"},{"key":"1720_CR27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fimmu.2015.00031","volume":"6","author":"NC Horton","year":"2015","unstructured":"Horton NC, Mathew PA (2015) NKp44 and natural cytotoxicity receptors as damage-associated molecular pattern recognition receptors. Front Immunol 6:31","journal-title":"Front Immunol"},{"key":"1720_CR28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fimmu.2013.00069","volume":"4","author":"K Hudspeth","year":"2013","unstructured":"Hudspeth K, Silva-Santos B, Mavilio D (2013) Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells. Front Immunol 4:69","journal-title":"Front Immunol"},{"key":"1720_CR29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4065\/81.2.247","volume":"81","author":"EJ Jabbour","year":"2006","unstructured":"Jabbour EJ, Estey E, Kantarjian HM (2006) Adult acute myeloid leukemia. Mayo Clin Proc 81:247\u2013260","journal-title":"Mayo Clin Proc"},{"key":"1720_CR30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277\u2013300","journal-title":"CA Cancer J Clin"},{"key":"1720_CR31","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/eji.201444500","volume":"44","author":"Z Khaznadar","year":"2014","unstructured":"Khaznadar Z, Henry G, Setterblad N, Agaugue S, Raffoux E, Boissel N, Dombret H, Toubert A, Dulphy N (2014) Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse. Eur J Immunol 44:3068\u20133080","journal-title":"Eur J Immunol"},{"key":"1720_CR32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/eji.1830050209","volume":"5","author":"R Kiessling","year":"1975","unstructured":"Kiessling R, Klein E, Pross H, Wigzell H (1975) \u201cNatural\u201d killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 5:117\u2013121","journal-title":"Eur J Immunol"},{"key":"1720_CR33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/eji.1830050208","volume":"5","author":"R Kiessling","year":"1975","unstructured":"Kiessling R, Klein E, Wigzell H (1975) \u201cNatural\u201d killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 5:112\u2013117","journal-title":"Eur J Immunol"},{"key":"1720_CR34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcyt.2014.09.007","volume":"17","author":"H Klingemann","year":"2015","unstructured":"Klingemann H (2015) Challenges of cancer therapy with natural killer cells. Cytotherapy 17:245\u2013249","journal-title":"Cytotherapy"},{"key":"1720_CR35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.it.2013.01.003","volume":"34","author":"J Koch","year":"2013","unstructured":"Koch J, Steinle A, Watzl C, Mandelboim O (2013) Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol 34:182\u2013191","journal-title":"Trends Immunol"},{"key":"1720_CR36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.blre.2014.08.002","volume":"28","author":"EF Krakow","year":"2014","unstructured":"Krakow EF, Bergeron J, Lachance S, Roy DC, Delisle JS (2014) Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatment. Blood Rev 28:249\u2013261","journal-title":"Blood Rev"},{"key":"1720_CR37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0047-6374(97)00045-6","volume":"96","author":"R Krishnaraj","year":"1997","unstructured":"Krishnaraj R (1997) Senescence and cytokines modulate the NK cell expression. Mech Ageing Dev 96:89\u2013101","journal-title":"Mech Ageing Dev"},{"key":"1720_CR38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","volume":"9","author":"LL Lanier","year":"2008","unstructured":"Lanier LL (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9:495\u2013502","journal-title":"Nat Immunol"},{"key":"1720_CR39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1474-9726.2010.00584.x","volume":"9","author":"M Garff-Tavernier Le","year":"2010","unstructured":"Le Garff-Tavernier M, Beziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, Debre P, Merle-Beral H, Vieillard V (2010) Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 9:527\u2013535","journal-title":"Aging Cell"},{"key":"1720_CR40","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.leukres.2014.05.014","volume":"38","author":"FS Lichtenegger","year":"2014","unstructured":"Lichtenegger FS, Lorenz R, Gellhaus K, Hiddemann W, Beck B, Subklewe M (2014) Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AML. Leuk Res 38:964\u2013969","journal-title":"Leuk Res"},{"key":"1720_CR41","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/leu.2012.87","volume":"26","author":"E Lion","year":"2012","unstructured":"Lion E, Willemen Y, Berneman ZN, Van TV, Smits EL (2012) Natural killer cell immune escape in acute myeloid leukemia. Leukemia 26:2019\u20132026","journal-title":"Leukemia"},{"key":"1720_CR42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","volume":"11","author":"HG Ljunggren","year":"1990","unstructured":"Ljunggren HG, Karre K (1990) In search of the \u2018missing self\u2019: MHC molecules and NK cell recognition. Immunol Today 11:237\u2013244","journal-title":"Immunol Today"},{"key":"1720_CR43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri2073","volume":"7","author":"HG Ljunggren","year":"2007","unstructured":"Ljunggren HG, Malmberg KJ (2007) Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 7:329\u2013339","journal-title":"Nat Rev Immunol"},{"key":"1720_CR44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.smim.2014.02.004","volume":"26","author":"F Locatelli","year":"2014","unstructured":"Locatelli F, Moretta F, Brescia L, Merli P (2014) Natural killer cells in the treatment of high-risk acute leukaemia. Semin Immunol 26:173\u2013179","journal-title":"Semin Immunol"},{"key":"1720_CR45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.smim.2014.03.002","volume":"26","author":"M Lopez-Botet","year":"2014","unstructured":"Lopez-Botet M, Muntasell A, Vilches C (2014) The CD94\/NKG2C\u00a0+\u00a0NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection. Semin Immunol 26:145\u2013151","journal-title":"Semin Immunol"},{"key":"1720_CR46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.mad.2005.01.004","volume":"126","author":"CT Lutz","year":"2005","unstructured":"Lutz CT, Moore MB, Bradley S, Shelton BJ, Lutgendorf SK (2005) Reciprocal age related change in natural killer cell receptors for MHC class I. Mech Ageing Dev 126:722\u2013731","journal-title":"Mech Ageing Dev"},{"key":"1720_CR47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/intimm\/10.7.981","volume":"10","author":"E Mariani","year":"1998","unstructured":"Mariani E, Mariani AR, Meneghetti A, Tarozzi A, Cocco L, Facchini A (1998) Age-dependent decreases of NK cell phosphoinositide turnover during spontaneous but not Fc-mediated cytolytic activity. Int Immunol 10:981\u2013989","journal-title":"Int Immunol"},{"key":"1720_CR48","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/1521-4141(200206)32:6<1524::AID-IMMU1524>3.0.CO;2-E","volume":"32","author":"E Mariani","year":"2002","unstructured":"Mariani E, Meneghetti A, Neri S, Ravaglia G, Forti P, Cattini L, Facchini A (2002) Chemokine production by natural killer cells from nonagenarians. Eur J Immunol 32:1524\u20131529","journal-title":"Eur J Immunol"},{"key":"1720_CR49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/asheducation-2013.1.247","volume":"2013","author":"JS Miller","year":"2013","unstructured":"Miller JS (2013) Therapeutic applications: natural killer cells in the clinic. Hematol Am Soc Hematol Educ Prog 2013:247\u2013253","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"1720_CR50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1742-4690-10-158","volume":"10","author":"JM Milush","year":"2013","unstructured":"Milush JM, Lopez-Verges S, York VA, Deeks SG, Martin JN, Hecht FM, Lanier LL, Nixon DF (2013) CD56negCD16(+) NK cells are activated mature NK cells with impaired effector function during HIV-1 infection. Retrovirology 10:158","journal-title":"Retrovirology"},{"key":"1720_CR51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1474-9728.2004.00107.x","volume":"3","author":"E Mocchegiani","year":"2004","unstructured":"Mocchegiani E, Malavolta M (2004) NK and NKT cell functions in immunosenescence. Aging Cell 3:177\u2013184","journal-title":"Aging Cell"},{"key":"1720_CR52","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cyto.a.22302","volume":"83","author":"E Montaldo","year":"2013","unstructured":"Montaldo E, Del ZG, Della CM, Mingari MC, Moretta A, De MA, Moretta L (2013) Human NK cell receptors\/markers: a tool to analyze NK cell development, subsets and function. Cytometry A 83:702\u2013713","journal-title":"Cytometry A"},{"key":"1720_CR53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.smim.2014.01.006","volume":"26","author":"E Montaldo","year":"2014","unstructured":"Montaldo E, Vacca P, Moretta L, Mingari MC (2014) Development of human natural killer cells and other innate lymphoid cells. Semin Immunol 26:107\u2013113","journal-title":"Semin Immunol"},{"key":"1720_CR54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","volume":"19","author":"A Moretta","year":"2001","unstructured":"Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197\u2013223","journal-title":"Annu Rev Immunol"},{"key":"1720_CR55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000365632","volume":"164","author":"L Moretta","year":"2014","unstructured":"Moretta L, Montaldo E, Vacca P, Del ZG, Moretta F, Merli P, Locatelli F, Mingari MC (2014) Human natural killer cells: origin, receptors, function, and clinical applications. Int Arch Allergy Immunol 164:253\u2013264","journal-title":"Int Arch Allergy Immunol"},{"key":"1720_CR56","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/eji.201243117","volume":"43","author":"A Muntasell","year":"2013","unstructured":"Muntasell A, Vilches C, Angulo A, Lopez-Botet M (2013) Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Eur J Immunol 43:1133\u20131141","journal-title":"Eur J Immunol"},{"key":"1720_CR57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.0105-2896.2005.00273.x","volume":"205","author":"DM Murasko","year":"2005","unstructured":"Murasko DM, Jiang J (2005) Response of aged mice to primary virus infections. Immunol Rev 205:285\u2013296","journal-title":"Immunol Rev"},{"key":"1720_CR58","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2004-07-2585","volume":"105","author":"P Nowbakht","year":"2005","unstructured":"Nowbakht P, Ionescu MC, Rohner A, Kalberer CP, Rossy E, Mori L, Cosman D, De LG, Wodnar-Filipowicz A (2005) Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias. Blood 105:3615\u20133622","journal-title":"Blood"},{"key":"1720_CR59","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbmt.2014.12.037","volume":"21","author":"JL Oyer","year":"2015","unstructured":"Oyer JL, Igarashi RY, Kulikowski AR, Colosimo DA, Solh MM, Zakari A, Khaled YA, Altomare DA, Copik AJ (2015) Generation of highly cytotoxic natural killer cells for treatment of acute myelogenous leukemia using a feeder-free, particle-based approach. Biol Blood Marrow Transplant 21:632\u2013639","journal-title":"Biol Blood Marrow Transplant"},{"key":"1720_CR60","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/embor.2008.12","volume":"9","author":"G Pawelec","year":"2008","unstructured":"Pawelec G, Solana R (2008) Are cancer and ageing different sides of the same coin? conference on cancer and ageing. EMBO Rep 9:234\u2013238","journal-title":"EMBO Rep"},{"key":"1720_CR61","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jlb.64.6.703","volume":"64","author":"G Pawelec","year":"1998","unstructured":"Pawelec G, Solana R, Remarque E, Mariani E (1998) Impact of aging on innate immunity. J Leukoc Biol 64:703\u2013712","journal-title":"J Leukoc Biol"},{"key":"1720_CR62","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood-2004-09-3548","volume":"105","author":"D Pende","year":"2005","unstructured":"Pende D, Spaggiari GM, Marcenaro S, Martini S, Rivera P, Capobianco A, Falco M, Lanino E, Pierri I, Zambello R, Bacigalupo A, Mingari MC, Moretta A, Moretta L (2005) Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112). Blood 105:2066\u20132073","journal-title":"Blood"},{"key":"1720_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/leu.2014.189","volume":"29","author":"A Rambaldi","year":"2015","unstructured":"Rambaldi A, Biagi E, Bonini C, Biondi A, Introna M (2015) Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches. Leukemia 29:1\u201310","journal-title":"Leukemia"},{"key":"1720_CR64","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","volume":"31","author":"DH Raulet","year":"2013","unstructured":"Raulet DH, Gasser S, Gowen BG, Deng W, Jung H (2013) Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol 31:413\u2013441","journal-title":"Annu Rev Immunol"},{"key":"1720_CR65","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2012-04-425397","volume":"121","author":"R Romee","year":"2013","unstructured":"Romee R, Foley B, Lenvik T, Wang Y, Zhang B, Ankarlo D, Luo X, Cooley S, Verneris M, Walcheck B, Miller J (2013) NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood 121:3599\u20133608","journal-title":"Blood"},{"key":"1720_CR66","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1182\/blood-2003-01-0019","volume":"102","author":"HR Salih","year":"2003","unstructured":"Salih HR, Antropius H, Gieseke F, Lutz SZ, Kanz L, Rammensee HG, Steinle A (2003) Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 102:1389\u20131396","journal-title":"Blood"},{"key":"1720_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00262-010-0898-x","volume":"60","author":"CJ Sanchez","year":"2011","unstructured":"Sanchez CJ, Le TT, Boehrer A, Knoblauch B, Imbert J, Olive D, Costello RT (2011) Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity. Cancer Immunol Immunother 60:1\u201313","journal-title":"Cancer Immunol Immunother"},{"key":"1720_CR68","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cyto.2012.12.023","volume":"61","author":"B Sanchez-Correa","year":"2013","unstructured":"Sanchez-Correa B, Bergua JM, Campos C, Gayoso I, Arcos MJ, Banas H, Morgado S, Casado JG, Solana R, Tarazona R (2013) Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels. Cytokine 61:885\u2013891","journal-title":"Cytokine"},{"key":"1720_CR69","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/icb.2011.15","volume":"90","author":"B Sanchez-Correa","year":"2012","unstructured":"Sanchez-Correa B, Gayoso I, Bergua JM, Casado JG, Morgado S, Solana R, Tarazona R (2012) Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients. Immunol Cell Biol 90:109\u2013115","journal-title":"Immunol Cell Biol"},{"key":"1720_CR70","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00262-011-1050-2","volume":"60","author":"B Sanchez-Correa","year":"2011","unstructured":"Sanchez-Correa B, Morgado S, Gayoso I, Bergua JM, Casado JG, Arcos MJ, Bengochea ML, Duran E, Solana R, Tarazona R (2011) Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands. Cancer Immunol Immunother 60:1195\u20131205","journal-title":"Cancer Immunol Immunother"},{"key":"1720_CR71","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.3390\/ijms150814632","volume":"15","author":"FC Schmeel","year":"2014","unstructured":"Schmeel FC, Schmeel LC, Gast SM, Schmidt-Wolf IG (2014) Adoptive immunotherapy strategies with cytokine-induced killer (CIK) cells in the treatment of hematological malignancies. Int J Mol Sci 15:14632\u201314648","journal-title":"Int J Mol Sci"},{"key":"1720_CR72","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(00)70060-4","volume":"4","author":"A Shibuya","year":"1996","unstructured":"Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, Kitamura T, Nicholl J, Sutherland GR, Lanier LL, Phillips JH (1996) DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4:573\u2013581","journal-title":"Immunity"},{"key":"1720_CR73","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1038\/sj.leu.2403985","volume":"19","author":"U Siegler","year":"2005","unstructured":"Siegler U, Kalberer CP, Nowbakht P, Sendelov S, Meyer-Monard S, Wodnar-Filipowicz A (2005) Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD\/SCID mice. Leukemia 19:2215\u20132222","journal-title":"Leukemia"},{"key":"1720_CR74","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0531-5565(99)00008-X","volume":"34","author":"R Solana","year":"1999","unstructured":"Solana R, Alonso MC, Pena J (1999) Natural killer cells in healthy aging. Exp Gerontol 34:435\u2013443","journal-title":"Exp Gerontol"},{"key":"1720_CR75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coi.2014.04.002","volume":"29","author":"R Solana","year":"2014","unstructured":"Solana R, Campos C, Pera A, Tarazona R (2014) Shaping of NK cell subsets by aging. Curr Opin Immunol 29:56\u201361","journal-title":"Curr Opin Immunol"},{"key":"1720_CR76","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0264-410X(99)00495-8","volume":"18","author":"R Solana","year":"2000","unstructured":"Solana R, Mariani E (2000) NK and NK\/T cells in human senescence. Vaccine 18:1613\u20131620","journal-title":"Vaccine"},{"key":"1720_CR77","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2006.05.003","volume":"24","author":"R Solana","year":"2006","unstructured":"Solana R, Pawelec G, Tarazona R (2006) Aging and innate immunity. Immunity 24:491\u2013494","journal-title":"Immunity"},{"key":"1720_CR78","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.smim.2012.04.008","volume":"24","author":"R Solana","year":"2012","unstructured":"Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T (2012) Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol 24:331\u2013341","journal-title":"Semin Immunol"},{"key":"1720_CR79","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, Powrie F, Vivier E (2013) Innate lymphoid cells\u2013a proposal for uniform nomenclature. Nat Rev Immunol 13:145\u2013149","journal-title":"Nat Rev Immunol"},{"key":"1720_CR80","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3324\/haematol.2013.087536","volume":"99","author":"K Stringaris","year":"2014","unstructured":"Stringaris K, Sekine T, Khoder A, Alsuliman A, Razzaghi B, Sargeant R, Pavlu J, Brisley G, de Lavallade H, Sarvaria A, Marin D, Mielke S, Apperley JF, Shpall EJ, Barrett AJ, Rezvani K (2014) Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia. Haematologica 99:836\u2013847","journal-title":"Haematologica"},{"key":"1720_CR81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00262-009-0724-5","volume":"59","author":"MJ Szczepanski","year":"2010","unstructured":"Szczepanski MJ, Szajnik M, Welsh A, Foon KA, Whiteside TL, Boyiadzis M (2010) Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors. Cancer Immunol Immunother 59:73\u201379","journal-title":"Cancer Immunol Immunother"},{"key":"1720_CR82","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1023\/A:1015476114409","volume":"22","author":"R Tarazona","year":"2002","unstructured":"Tarazona R, Casado JG, Delarosa O, Torre-Cisneros J, Villanueva JL, Sanchez B, Galiani MD, Gonzalez R, Solana R, Pena J (2002) Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. J Clin Immunol 22:176\u2013183","journal-title":"J Clin Immunol"},{"key":"1720_CR83","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ni1580","volume":"9","author":"M Terme","year":"2008","unstructured":"Terme M, Ullrich E, Delahaye NF, Chaput N, Zitvogel L (2008) Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol 9:486\u2013494","journal-title":"Nat Immunol"},{"key":"1720_CR84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.leu.2405040","volume":"22","author":"S Verheyden","year":"2008","unstructured":"Verheyden S, Demanet C (2008) NK cell receptors and their ligands in leukemia. Leukemia 22:249\u2013257","journal-title":"Leukemia"},{"key":"1720_CR85","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1158\/1078-0432.CCR-13-0505","volume":"19","author":"A Wiernik","year":"2013","unstructured":"Wiernik A, Foley B, Zhang B, Verneris MR, Warlick E, Gleason MK, Ross JA, Luo X, Weisdorf DJ, Walcheck B, Vallera DA, Miller JS (2013) Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition. Clin Cancer Res 19:3844\u20133855","journal-title":"Clin Cancer Res"},{"key":"1720_CR86","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1007\/s00018-011-0797-0","volume":"68","author":"B Zafirova","year":"2011","unstructured":"Zafirova B, Wensveen FM, Gulin M, Polic B (2011) Regulation of immune cell function and differentiation by the NKG2D receptor. Cell Mol Life Sci 68:3519\u20133529","journal-title":"Cell Mol Life Sci"},{"key":"1720_CR87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/cei.12095","volume":"173","author":"Q Zhou","year":"2013","unstructured":"Zhou Q, Gil-Krzewska A, Peruzzi G, Borrego F (2013) Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy. Clin Exp Immunol 173:131\u2013139","journal-title":"Clin Exp Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-015-1720-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1720-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T10:48:01Z","timestamp":1566816481000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-015-1720-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,10]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["1720"],"URL":"https:\/\/doi.org\/10.1007\/s00262-015-1720-6","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,10]]}}}